AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives. Our commitment is measured by the
impact we make – to patients, to our communities, and to the world. Our 50,000 employees strive to make a remarkable impact that lasts, driven by our compassion for people,
commitment to innovation and inclusion, service to the community and uncompromising integrity. Today our products help more than 62 million people living in more than 175
countries, and we are making significant advancements with a robust pipeline of potential new medicines as we look to find the treatments of tomorrow.

 Lorestry by Alea Diagnostics is the creator of infant mental health and early child development monitoring, which has been recommended by the American Academy of Pediatrics (AAP) and the CDC.  Through the Lorestry® iOS app, parents are engaged and empowered with on-demand development progression reports mapped to global health codes. They receive help navigating to federally funded evaluations, diagnosis, and treatment resources when social-emotional, cognitive, physical, or language milestones are missed. For children receiving high-cost interventions for conditions such as autism, Lorestry monitors clinical effectiveness, care, and navigation experiences and developmental outcomes to age seven.

At AMPS, we understand the challenges organizations face in managing healthcare costs. That’s why we take a personal and consultative approach, helping our clients make informed decisions every step of the way. Whether you’re a self-funded employer, broker, TPA, health system, health plan, or reinsurer, we vow to meet you where you are in your healthcare cost savings journey. Our heartfelt mission is to help you reduce medical and pharmacy spend without sacrificing valuable benefits or quality healthcare options, keeping your members satisfied and healthy.

apree health brings together a best-in-class engagement platform with an advanced primary care model to provide a vastly better health and care experience, improve outcomes, and significantly lower the total cost of care for a population. Its proven solutions are built on a robust data and technology foundation that provides a rich understanding of each person, a navigation experience that engages individuals in their health and care, and an integrated care team that manages the individual's whole health. apree health was formed when leading advanced primary care provider Vera Whole Health merged with digital health innovator Castlight Health in 2022. Both companies were founded in 2008. apree health partners with top U.S. employers, leading provider groups, and some of the country's largest, most progressive health plans. Visit us at apreehealth.com.

Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world. For more information on Astellas, please visit: https://www.astellas.com/us You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma-us.

Digbi Health offers the only precision biology based care program that treats 3 of the top 4 cost categories - Obesity, Cardiometabolic/T2D and GI Health, along with 400 other medical conditions - replacing the tangle of point solutions for employers with an integrated holistic offering. Leveraging precision biology including genetics, gut microbiome, and glucose monitoring, Digbi Health creates personalized health management programs that reduce the need for medications and guides individuals on a path to a healthier, disease free life.

Included Health is a new kind of healthcare company. We combine people and technology to guide and deliver care differently. Working with employers and health plans nationwide, we provide millions of people with a healthcare experience that is more personalized, equitable, affordable, and cohesive. With us, it’s all included; care and support online, around the corner, and in the home for everyday and urgent needs including primary, specialty, and behavioral healthcare. Our model is designed to treat people better. Learn more at includedhealth.com.

The Lactation Network (TLN) is the only national provider of expert, in-person lactation care delivered by international board-certified lactation consultants (IBCLCs). TLN consists of 2,000+ IBCLCs nationwide, and provides comprehensive lactation care, educational resources, and breast pumps to thousands of parents every month.

MSK Direct is a national cancer benefits solution that provides more than 7.2 million employees, union members, and their families with equitable, personalized access to the lifesaving discoveries and subspecialized expertise of Memorial Sloan Kettering Cancer Center (MSK). With services that span screening and prevention, diagnosis, treatment, and life beyond cancer for both adult and pediatric patients, MSK Direct measurably improves health outcomes and drives value through every person’s unique cancer journey.

Comprehensive Care Sustainability Collaborative (CCSC) is an ongoing quality improvement/cost management initiative supported by the National Bleeding Disorders Foundation, formerly NHF. The aim of CCSC is to provide payers with knowledge crucial for managing the high costs associated with hemophilia and to augment the sustainability of Hemophilia Treatment Centers (HTCs) by overcoming communication gaps to increase connectivity between all stakeholders.  Purchasers of health care play a vital role in improving access to quality care for patients with hemophilia. The goal is to improve patient outcomes while containing or even lowering the cost of care for this high cost, chronic disease. Join CCSC to gain insights from hemophilia providers and payer experts, access useful management tools and resources, and advance your collaboration with HTCs and employers. Even if you do not manage many members impacted by hemophilia, the lessons learned from CCSC are applicable to managing any high-cost, chronic conditions.

The National Cancer Treatment Alliance (NCTA) is a clinically integrated network (CIN) of leading oncology practices and pharmacies across the country.

The unique structure of a CIN allows NCTA practices to work together and directly with health plan sponsors to ensure patients receive high quality, patient-centered, and lower-cost cancer care. NCTA member practices are accountable for the care they provide and must prove their success through tracking and reporting of quality and value measures.

NCTA is a benefit corporation subsidiary of the Community Oncology Alliance (COA), a national non-profit dedicated solely to independent, community oncology practices and, most importantly, the patients they serve. Through the NCTA, we are seeking to provide a solution to employers and health plan sponsors who are increasingly frustrated by an expensive, complex, and unfriendly cancer care system.

Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment

Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. are the US-based indirect subsidiaries of the global healthcare company Otsuka Pharmaceutical Co. Ltd with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka’s US companies share a deep commitment to the development and commercialization of innovative products in the spaces of neuroscience, nephrology, and digital medicine. We have an unwavering belief in doing more and going above and beyond — under any circumstances- so that patients can push past the limitations of their disease and achieve more than they thought was possible every day. At Otsuka, we hold a deep respect for the value of every mind. We believe that the human mind is infinitely valuable, fostering imagination, intelligence, perception, and so much more. By recognizing this value, we have the power to change the trajectory of people’s lives. This is why we will not rest until mental illness is approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention. Through products, programs, policies, and advocacy, Otsuka-people will defy any limitation that stands in their way until every mind is valued. Discover our commitment to health for every mind: Valued Minds | Otsuka US (otsuka-us.com)

Technology is not only changing our lives, but also revolutionizing human health. By uniting transformational technology and cutting-edge science, Pfizer is pioneering biopharmaceutical innovations that not only treat difficult diseases—but can cure or prevent them. Every day, Pfizer is working to discover breakthroughs that change patients’ lives and opening new worlds of medical possibilities. We’re applying equal intelligence and passion to help ensure these treatments and therapies are accessible to all. Pfizer is amplifying the power of science and technology, daring more courageously and inquiring more deeply to make what was once unimaginable a reality.

Progyny is a leading fertility and family building benefits solution currently serving 390+ clients, covering 5.4M lives. Infertility impacts 1 in 8 couples and family building is expanding, with more single parents by choice and LGBTQ+ needing to use assisted reproductive technology, adoption, or surrogacy to grow their family.   Progyny works with self- and fully insured clients in the US, Canada and globally, and our services span preconception, fertility, maternity, postpartum and menopause. Our model includes clinically integrated member support with robust digital tools (virtual care, app, etc.); the largest fertility focused network of providers with ongoing management for quality; equitable and comprehensive plan coverage that includes male factor fertility coverage, adoption and surrogacy support; and integrated Rx.   All together, Progyny helps members get pregnant faster and have healthier pregnancies and babies, requiring less treatment and medication. This results in key healthcare savings for employers as well as enabling them to meet DEI goals, mental health priorities and attract/retain needs. Progyny completed its initial public offering in 2019 and trades on Nasdaq under the ticker PGNY.

TARA Mind is a public benefit corporation whose mission is to expand safe and equitable access to psychedelic-assisted therapy (PAT). TARA Mind partners with employers across the country to offer safe, legal and rapidly effective PAT to their employees as a covered insurance benefit. For too many people traditional therapies have failed to get them to remission. Individuals struggling with treatment resistant depression miss an average of 36 work days per year, have a 40% higher turnover rate, and have an average annual cost of over $50,000 per year. Since its founding in 2022, TARA Mind has built a premier network of licensed therapists and prescribers to scale access to care to those who need it most. We’re dedicated to changing the status quo of poor mental health outcomes while driving meaningful savings to employers- learn more about how you can break down barriers and offer coverage to life changing PAT at TARAMind.com.

TELA Bio is a commercial stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Our growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. We are committed to delivering our advanced technologies with a strong economic value proposition to assist surgeons and institutions in providing next-generation soft-tissue repair solutions to more patients worldwide.